Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Kill currently holds 162,809 shares of COGENTIX MEDICAL INC /DE/ (CGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Kill has been a net buyer of CGNT stock. They have purchased $216.4K and sold $0 worth of shares.
Robert Kill's most recent insider trade was on Nov 13, 2025, when they sold 56,603 shares at $0.00 per share.
Robert Kill serves as Executive at COGENTIX MEDICAL INC /DE/ (CGNT). They have executed 41 insider transactions totaling $216.4K over their tenure at the company.
Robert Kill holds the position of Executive at COGENTIX MEDICAL INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Robert Kill has shown a buying trading pattern, with $216.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert Kill was on Jul 12, 2010, when they sold $1.9M worth of VRAD shares. This transaction involved 110,091 shares at $17.25 per share.
Robert Kill currently owns 162,809 shares of COGENTIX MEDICAL INC /DE/ (CGNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Kill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Kill has 41 Form 4 filings on record as an insider at COGENTIX MEDICAL INC /DE/.
Set alerts for Robert Kill and 40,000+ other insiders.